All Programs

Use the tool below to view all available Global Neurology Academy Series

CME/CE Meeting
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
July 30, 2025
Toronto
Learn more
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
NeuroFrontiers
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
- Mary Rensel, MD, FAAN, ABIHM
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiers
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
- Maxwell H. Levy, MD
Debunking gMG Myths: Counseling Strategies That Change the Conversation
Debunking gMG Myths: Counseling Strategies That Change the Conversation
NeuroFrontiers
Debunking gMG Myths: Counseling Strategies That Change the Conversation
- Maxwell H. Levy, MD
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiers
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
- Rosaline Quinlivan
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiers
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
- Richard Nowak, MD, MS
Reducing the Burden of gMG with a Novel B-Cell Therapy
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiers
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
- Andrew J. Solomon, MD
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiers
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
- Kelly Sloane, MD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Global Neurology Academy
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
- Yinan Zhang, MD
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Global Neurology Academy
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title

Share on ReachMD